Navigation Links
Summit VetPharm Addressed Veterinarian Diverted Vectra 3D(TM)
Date:2/8/2008

FORT LEE, N.J., Feb 8 /PRNewswire/ -- This week, Summit VetPharm identified the first instance of a veterinarian who was diverting its veterinary exclusive Vectra 3D(TM) flea and tick product. This situation, where product was found available for sale on a popular website targeting pet owners, is a clear violation of the Company's anti-diversion policy.

Summit VetPharm, after confirming the identity of the California veterinarian, swiftly implemented corrective action against this individual. By utilizing the proprietary Summit VetPharm Bloodhound(TM) track and trace technology, the company was able to immediately pinpoint where the violation had occurred. Within six hours of legal notification to the veterinarian, the diverted product was no longer available for sale.

"I am delighted that our Bloodhound track and trace technology provided us with rapid identification which allowed us to pursue immediate action against this individual who appears to have willfully violated our signed anti- diversion contract and placed our product outside the veterinary channel for sale," stated Julia Stephanus, president and CEO of Summit VetPharm. Vectra 3D and all Summit VetPharm products are exclusively dispensed by licensed veterinarians. We will not tolerate product diversion because it undermines the relationship between veterinarians and pet owners and raises questions about product integrity."

"Veterinary response across the country has been unanimously positive about Summit VetPharm's commitment to the profession," stated Dr. Albert Ahn, Senior Director of Veterinary Services. "Over the years, veterinarians have expressed their concerns to me that companies were unwilling or unable to stop unauthorized product diversion. The veterinarians I have spoken with are genuinely impressed with the commitment that Summit VetPharm has made. One of the core principles upon which our company was founded was the commitment to ensure that our products are dev
'/>"/>

SOURCE Summit VetPharm
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Campbell Alliance Brand Management Practice to Discuss Managing Launch Logistics at the EyeForPharma Oncology Summit
2. The Dark Report and Siemens Introduce the Worlds First Integrated Molecular Summit
3. Seven Summits Research Releases Alerts on XOM, MER, DRYS, CSC, and PDLI
4. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
5. Lux Executive Summit announces 2007 speakers
6. MHA Announces: Tommy Thompson to be Keynote Speaker at The MHA 5th Annual Business Summit
7. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
8. Boydens Summit Practice Featured in the September Issue of New Jersey Business Magazine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... provider of strategic communications services to corporations and organizations preparing for ... United States and Europe , today ... to the firm,s Washington, D.C. office. ... years of service as Associate Commissioner for the Office of External ...
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational research ... Alliqua is an emerging biomedical company acquiring, developing, manufacturing, ... market. , Free report download: http://equitiesiq.com/reports/alliqua/ , ... management team and Board, which launched the company’s new ...
(Date:1/14/2014)... Md. , Jan. 14, 2014  Organovo announced today ... the National Institutes of Health (NIH) to help scientists ... treatments to patients on a faster timeline. Organovo is ... (NCATS) and the National Eye Institute (NEI) to develop ...
(Date:1/14/2014)... Canada (PRWEB) January 14, 2014 In ... its motives and methods in product development and promotion ... the industry. This mistrust, fueled by concerns about the ... fed by reports of spectacular fines to the world’s ...
Breaking Biology Technology:Former FDA Associate Commissioner Returns To 3D Communications 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... , AURORA, Ontario, Sept. 8 Helix BioPharma Corp. (TSX, ... announced private placement of 6,625,000 units at $2.05 per unit. ... and one common share purchase warrant, with each common share purchase warrant ... the Company at a price of $2.87 for up to three years ...
... , CAMBRIDGE, Mass., Sept. 8 ... the development of next-generation cellulosic ethanol and high-performance specialty enzymes, ... of the Company,s common stock will take effect after market ... continue to trade on the NASDAQ Global Market under the ...
... , FORT LAUDERDALE, Fla., Sept. 8 South Florida ... launched an important joint event with the state,s life sciences organization, ... Lauderdale on August 27, to hear experts from Scripps Florida, University ... and information technology. , , Presentations ...
Cached Biology Technology:Helix BioPharma Closes Private Placement 2Helix BioPharma Closes Private Placement 3Verenium Announces Reverse Stock Split to Take Effect September 9 2Verenium Announces Reverse Stock Split to Take Effect September 9 3Verenium Announces Reverse Stock Split to Take Effect September 9 4South Florida Technology Alliance and BioFlorida Joint-Event Draws Big Names and Big Crowd 2South Florida Technology Alliance and BioFlorida Joint-Event Draws Big Names and Big Crowd 3
(Date:4/17/2014)... , Respiratory syncytial virus (RSV) is a ... life-threating illness in very young and elderly populations. ... enters host cells through the fusion protein RSV ... interfering peptides that prevent bundle formation limit RSV ... susceptible to degradation. In this issue of the ...
(Date:4/17/2014)... and Professor Luca Razzari of the nergie Matriaux ... grants from the John R. Evans Leaders Fund ... the acquisition of state-of-the-art biotech and nanophotonics equipment. ... from the Ministre de l,Enseignement suprieur, de la ... (MESRST). These new laboratories will help us develop ...
(Date:4/17/2014)... to produce hydrogen sulfide in order to properly multiply ... from the Center for Craniofacial Molecular Biology at the ... Songtao Shi, principal investigator on the project, said the ... the flow of calcium ions. The essential ions activate ... or the creation of new bone tissue, and keeps ...
Breaking Biology News(10 mins):JCI online ahead of print table of contents for April 17, 2014 2JCI online ahead of print table of contents for April 17, 2014 3JCI online ahead of print table of contents for April 17, 2014 4JCI online ahead of print table of contents for April 17, 2014 5JCI online ahead of print table of contents for April 17, 2014 6New state-of-the-art biotech and nanotech equipment for INRS 2
... a protein critical to enabling the brain to talk to ... researchers report. The finding that an antibody to ... brain-muscle interaction helps explain why as many as 10 percent ... muscle weakness, yet their blood provides no clue of the ...
... of brain cell that tamps down stem cell activity ... progeny, Johns Hopkins researchers report. Understanding how these new ... how to behave is of special interest because changes ... as Alzheimer,s, mental illness and aging. "We,ve ...
... have in common? Based on work by scientists at the European ... same part of the brain reacts to both. In a study ... at least in mice different types of fear are ... out those fears in the same way. The findings could have ...
Cached Biology News:New cause found for muscle-weakening disease myasthenia gravis 2New cause found for muscle-weakening disease myasthenia gravis 3SIGNAL found to enhance survival of new brain cells 2What are you scared of? 2
... variety of solvent vapors that can contaminate and ... (GCF400) allows for the collection of liquid into ... cooling time minimizes waiting period., , Easy ... , -50?C Temerature for ...
... Protein Phosphatase-2A (PPase-2A) is a serine/threonine ... It is isolated as the heterodimer of ... has the ability to dephosphorylate the a-subunit ... subunit, PPase-2A has broad substrate specificity and ...
... is a high performance spectral scanning ... incubator. With the advanced SkanIt Software ... for drug discovery assay development. Varioskan ... intensity, time-resolved fluorescence and photometric assays ...
... Effectively condenses and traps a wide variety of ... oil. Easy-to-use glass condensation flask (GCF400) allows for the ... easy draining. Rapid cooling time minimizes waiting period., ... high volatile solvents , ...
Biology Products: